AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


American Journal of Public Health, Vol. 85, Issue 6 771-776, Copyright © 1995 by American Public Health Association

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garrard, J
Right arrow Articles by Dowd, B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garrard, J
Right arrow Articles by Dowd, B
The impact of the 1987 federal regulations on the use of psychotropic drugs in Minnesota nursing homes.

J Garrard, V Chen and B Dowd

Institute for Health Services Research, School of Public Health, University of Minnesota, Minneapolis 55455-0381, USA.

OBJECTIVES. The purpose of this study was to examine prevalence rates of psychotropic drug use by elderly nursing home residents 3 years before and 1 year after implementation of the 1987 Omnibus Budget Reconciliation Act drug regulations throughout the United States on October 1, 1990. METHODS. A cohort study was conducted of elderly nursing home residents, for each of 4 study years (approximately 33,000 residents per year), of all nursing homes (n = 372) in Minnesota certified by Medicare and Medicaid. Data included (1) health status assessment and psychotropic drug use; (2) nursing home and care characteristics; and (3) county geographic and population characteristics. RESULTS. Annual rates of antipsychotic drug use declined by one third over the 4-year period (23%, 22%, 19%, and 15% from 3 years before enforcement of the regulations to 1 year afterward). All differences were statistically significant. Antianxiety use rates were 11%, 12%, 12%, and 12%, respectively, and antidepressant use rates were 14%, 15%, 16%, 16%, respectively, for the 4 years. The latter two classes of drugs were not affected directly by the regulations. CONCLUSIONS. Declines in the rates of antipsychotic drug use appear to be associated with anticipation of the regulations the year before and as the result of the regulations the year after the October 1990 implementation. A hypothesized medication shift to benzodiazepine drugs was not observed.




This article has been cited by other articles:


Home page
AJGPHome page
P. S. Nishtala, A. J. McLachlan, J. S. Bell, and T. F. Chen
Psychotropic Prescribing in Long-Term Care Facilities: Impact of Medication Reviews and Educational Interventions
Am J Geriatr Psychiatry, August 1, 2008; 16(8): 621 - 632.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
P. A. Rochon, T. A. Stukel, S. E. Bronskill, T. Gomes, K. Sykora, W. P. Wodchis, M. Hillmer, A. Kopp, J. H. Gurwitz, and G. M. Anderson
Variation in Nursing Home Antipsychotic Prescribing Rates
Arch Intern Med, April 9, 2007; 167(7): 676 - 683.
[Abstract] [Full Text] [PDF]


Home page
Med Care Res RevHome page
M. P. Hillmer, W. P. Wodchis, S. S. Gill, G. M. Anderson, and P. A. Rochon
Nursing Home Profit Status and Quality of Care: Is There Any Evidence of an Association?
Med Care Res Rev, April 1, 2005; 62(2): 139 - 166.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
G. S. Winzelberg
The Quest for Nursing Home Quality: Learning History's Lessons
Arch Intern Med, November 24, 2003; 163(21): 2552 - 2556.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
J. M. Ryan, S. W. Kidder, L. A. Daiello, and P. N. Tariot
Mental Health Services in Nursing Homes: Psychopharmacologic Interventions in Nursing Homes: What Do We Know and Where Should We Go?
Psychiatr Serv, November 1, 2002; 53(11): 1407 - 1413.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
B. L. Svarstad and J. K. Mount
Effects of Residents' Depression, Sleep, and Demand for Medication on Benzodiazepine Use in Nursing Homes
Psychiatr Serv, September 1, 2002; 53(9): 1159 - 1165.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
B. L. Svarstad, J. K. Mount, and W. Bigelow
Variations in the Treatment Culture of Nursing Homes and Responses to Regulations to Reduce Drug Use
Psychiatr Serv, May 1, 2001; 52(5): 666 - 672.
[Abstract] [Full Text] [PDF]


Home page
Research on AgingHome page
D. A. McKenzie, J. P. Mullooly, B. H. McFarland, J. A. Semradek, and L. E. McCamant
Changes in Antipsychotic Drug Use Following Shifts in Policy: A Multilevel Analysis
Research on Aging, March 1, 1999; 21(2): 304 - 337.
[Abstract] [PDF]


Home page
Psychiatr. Serv.Home page
M. Snowden and P. Roy-Byrne
Mental Illness and Nursing Home Reform: OBRA-87 Ten Years Later
Psychiatr Serv, February 1, 1998; 49(2): 229 - 233.
[Abstract] [Full Text]


Home page
American Journal of Medical QualityHome page
C. B. Moseley
The Impact of Federal Regulations on Urethral Catheterization in Virginia Nursing Homes
American Journal of Medical Quality, December 1, 1996; 11(4): 222 - 226.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Public Health Association